The global downstream processing market size is expected to
reach USD 49.9 billion by 2027, expanding at a CAGR of 13.1%, according to a
new report by Grand View Research, Inc. The growing demand for advanced
technologies in the purification of recombinant proteins produced by animal
cell cultures to create high-value products of modern biotechnology propels
market growth.
The downstream processing technology is
being increasingly used in both laboratory and industrial-scale bioprocessing
applications owing to a growing demand for biologics, which is anticipated to
boost industry growth. In addition, the advantages offered by the use of
single-use bioprocessing equipment are also expected to drive the growth of the
market.
According to a recent study conducted
by GE Healthcare, the application of single-use bioprocessing equipment reduced
nearly 55% of the total impact across five impact categories. These categories
included natural resources, ecosystem quality, climate change, human health,
and freshwater withdrawal. This study was associated with the development of
monoclonal antibodies.
The growth of the market is
considerably restrained by high cost of the procedure and a lack of skilled
professionals. The industry players are keen on adopting outsourcing activities
and contract manufacturing organizations are helping pharma manufacturers to
optimize their downstream processing workflow and minimize their initial
capital investment costs. The industry players are also increasing their
R&D investments to expand their product pipeline and strengthen their
position in the market.
Browse full research report on Downstream Processing Market: https://www.grandviewresearch.com/industry-analysis/downstream-processing-market
Further key findings from the report suggest:
- Biopharmaceuticals is a major growth prospect and many
healthcare entities have estimated that the innovation in bioprocessing
will fuel the advancement of this sector and drive the expansion of the
market
- Frequent usage of chromatography systems in the downstream
process to achieve the highest level of purity of the end product is
attributive to the largest share of the chromatography product segment in
2019
- Filters are expected to witness an attractive growth owing to
its benefits of reduction in operating costs and an increase in adoption
of membrane filters
- Purification by chromatography is the highest
revenue-generating technique segment in 2019 and is anticipated to remain
so throughout the forecast period
- Antibiotic production has demonstrated huge demand over the
past few years owing to its proven effectiveness in treating various
diseases
- Moreover, the increasing incidence of antibiotic resistance
has boosted the development of new antibiotic products at an industrial
scale
- Rigorous research towards therapeutic applications of
monoclonal antibodies boosts the growth of the antibodies production
segment
- Some of the key players operating in downstream processing
market are GE Healthcare; Merck KGaA; Sartorius Stedim Biotech S.A.;
Thermo Fisher Scientific Inc.; and Danaher Corporation
- Other prominent players include Repligen, 3M Company,
Eppendorf AG, Boehringer Ingelheim International GmbH, Corning
Corporation, Lonza Group Ltd, Dover Corporation, Ferner PLC, and Ashai
Kasei.
Browse
request sample of this report by Grand View Research: https://www.grandviewresearch.com/industry-analysis/downstream-processing-market/request/rs1
Grand View Research has segmented the global downstream processing
market on the basis of product, technique, application, and region:
Downstream Processing Product Outlook (Revenue, USD Million, 2016
- 2027)
- Chromatography
Systems
- Filters
- Evaporators
- Centrifuges
- Dryers
- Others
Downstream Processing Technique Outlook (Revenue, USD Million,
2016 - 2027)
- Cell
Disruption
- Solid-liquid
separation
- Filtration
- Centrifugation
- Concentration
- Evaporation
- Membrane
filtration
- Purification
by Chromatography
- Formulation
Downstream Processing Application Outlook (Revenue, USD Million,
2016 - 2027)
- Antibiotic
Production
- Hormone
Production
- Antibodies
Production
- Enzyme
Production
- Vaccine
Production
Downstream Processing Regional Outlook (Revenue, USD Million, 2016
- 2027)
- North
America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- Asia
Pacific
- Japan
- China
- India
- Latin
America
- Brazil
- Mexico
- Middle
East and Africa (MEA)
- South
Africa
- UAE
About
Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
For
more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment